Page de couverture de Cardiology @Point of Care Podcasts

Cardiology @Point of Care Podcasts

Cardiology @Point of Care Podcasts

Auteur(s): @Point of Care
Écouter gratuitement

À propos de cet audio

Our @Point of Care Cardiology Podcasts have healthcare experts discussing and providing information related to cardiology diagnosis, treatment, management, and other important information.Copyright 2021 At Point of Care, LLC. All rights reserved. Hygiène et mode de vie sain Troubles et maladies
Épisodes
  • S1:E2 – Cardiology Journal Club: Treating the Pandemic Heart
    Feb 15 2021
    The Covid-19 pandemic has hit patients with cardiovascular disease particularly hard. Moreover, cardiovascular disease sequelae are plaguing Covid-19 patients who did not have heart disease to begin with. Our faculty discusses several papers related to cardiology issues as well as what they are seeing in their own clinics.
    Voir plus Voir moins
    32 min
  • S6:E1 – Don't Miss This: A Clinician's Call to Greater ATTR-CM Awareness and Early Diagnosis
    May 15 2025

    In this episode, our Faculty, Dr. Nitasha Sarswat and Tracy Joshi, DNP, discuss the often misdiagnosed condition transthyretin amyloid cardiomyopathy. What are the diagnostic red flags clinicians should be aware of, and what diagnostic tools are helpful to ensure their patients get the right diagnosis?

    Visit https://suitehome.atpointofcare.com/library/2684.11/page/0?subdomain=amyloidosis to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

    Voir plus Voir moins
    29 min
  • S2:E1 – SGLT-2 Inhibitors Morning Commute: Widening Benefit
    Mar 30 2021

    Visit http://morningcommutepodcast.com/SGLT2inhibitors4 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode Dr. James Januzzi and Dr. Silvio Inzucchi will discuss SGLT-2 inhibition in cardiovascular risk reduction by taking a look at some of the pivotal clinical trial data.

    Voir plus Voir moins
    Moins d'une minute
Pas encore de commentaire